Masks trigger facial seborrheic dermatitis and psoriasis : evidence from a multicenter, case-control study during COVID-19 pandemic
BACKGROUND: Wearing masks is an optimal preventive strategy during COVID-19 pandemic, but it may increase facial sebum production. However, few case reports have described seborrheic dermatitis (SeBD) and psoriasis (PsO) flares due to masks. Hence, we conducted a multicenter study to clarify the possibility of increased SeBD and PsO flares in association with mask wearing during the COVID-19 pandemic.
METHODS: This multicenter study enrolled patients with a diagnosis of facial SeBD and PsO. All dermatological consultations were conducted in teledermatology at baseline (T0) and after 1 month (T1) Of >6 hours/day wearing mask. PsO patients were assessed using PsO Area and Severity Index (PASI) and self-administered PASI (SAPASI), whilst SeBD patients with symptom scale of seborrheic dermatitis' (SSSD) and seborrheic dermatitis area and severity index (SEDASI).
RESULTS: A total of 33 (20 males, 13 females, average age 43.61±9.86) patients with PsO and 33 (20 males, 13 females, average age 44.00±8.58) with SeBD were enrolled. After 1 month, PsO patients displayed higher values of both PASI and SAPASI (P<0.0001), while SeBD patients experienced a flare, as testified by the increment of both SSSD and SEDASI (P<0.0001). Mask type did not seem to influence the flare severity.
CONCLUSIONS: Masks remain an optimal preventive strategy during COVID-19 pandemic, but patients with PsO and SeBD may experience facial flares. Thus, therapeutic approach should be more aggressive in these groups of patients to counteract the triggering effect of masks.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:157 |
---|---|
Enthalten in: |
Italian journal of dermatology and venereology - 157(2022), 5 vom: 13. Okt., Seite 419-423 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Damiani, Giovanni [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.10.2022 Date Revised 11.10.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.23736/S2784-8671.22.07246-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343500280 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343500280 | ||
003 | DE-627 | ||
005 | 20231226020603.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.23736/S2784-8671.22.07246-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1144.xml |
035 | |a (DE-627)NLM343500280 | ||
035 | |a (NLM)35829673 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Damiani, Giovanni |e verfasserin |4 aut | |
245 | 1 | 0 | |a Masks trigger facial seborrheic dermatitis and psoriasis |b evidence from a multicenter, case-control study during COVID-19 pandemic |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.10.2022 | ||
500 | |a Date Revised 11.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Wearing masks is an optimal preventive strategy during COVID-19 pandemic, but it may increase facial sebum production. However, few case reports have described seborrheic dermatitis (SeBD) and psoriasis (PsO) flares due to masks. Hence, we conducted a multicenter study to clarify the possibility of increased SeBD and PsO flares in association with mask wearing during the COVID-19 pandemic | ||
520 | |a METHODS: This multicenter study enrolled patients with a diagnosis of facial SeBD and PsO. All dermatological consultations were conducted in teledermatology at baseline (T0) and after 1 month (T1) Of >6 hours/day wearing mask. PsO patients were assessed using PsO Area and Severity Index (PASI) and self-administered PASI (SAPASI), whilst SeBD patients with symptom scale of seborrheic dermatitis' (SSSD) and seborrheic dermatitis area and severity index (SEDASI) | ||
520 | |a RESULTS: A total of 33 (20 males, 13 females, average age 43.61±9.86) patients with PsO and 33 (20 males, 13 females, average age 44.00±8.58) with SeBD were enrolled. After 1 month, PsO patients displayed higher values of both PASI and SAPASI (P<0.0001), while SeBD patients experienced a flare, as testified by the increment of both SSSD and SEDASI (P<0.0001). Mask type did not seem to influence the flare severity | ||
520 | |a CONCLUSIONS: Masks remain an optimal preventive strategy during COVID-19 pandemic, but patients with PsO and SeBD may experience facial flares. Thus, therapeutic approach should be more aggressive in these groups of patients to counteract the triggering effect of masks | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
700 | 1 | |a Finelli, Renata |e verfasserin |4 aut | |
700 | 1 | |a Kridin, Khalaf |e verfasserin |4 aut | |
700 | 1 | |a Pacifico, Alessia |e verfasserin |4 aut | |
700 | 1 | |a Buja, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Bragazzi, Nicola L |e verfasserin |4 aut | |
700 | 1 | |a Malagoli, Piergiorgio |e verfasserin |4 aut | |
700 | 1 | |a Savoia, Paola |e verfasserin |4 aut | |
700 | 1 | |a Gironi, Laura C |e verfasserin |4 aut | |
700 | 1 | |a Grada, Ayman |e verfasserin |4 aut | |
700 | 1 | |a Conic, Rosalynn R |e verfasserin |4 aut | |
700 | 1 | |a Linder, Dennis |e verfasserin |4 aut | |
700 | 1 | |a Micali, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Pigatto, Paolo D |e verfasserin |4 aut | |
700 | 0 | |a Young Dermatologists Italian Network |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Italian journal of dermatology and venereology |d 2021 |g 157(2022), 5 vom: 13. Okt., Seite 419-423 |w (DE-627)NLM286411903 |x 2784-8450 |7 nnns |
773 | 1 | 8 | |g volume:157 |g year:2022 |g number:5 |g day:13 |g month:10 |g pages:419-423 |
856 | 4 | 0 | |u http://dx.doi.org/10.23736/S2784-8671.22.07246-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 157 |j 2022 |e 5 |b 13 |c 10 |h 419-423 |